Galactan sulfate
Latest Information Update: 14 Jul 1998
At a glance
- Originator Rega Institute for Medical Research
- Class Antivirals; Polysaccharides
- Mechanism of Action HIV envelope protein gp120 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections; HIV infections
Most Recent Events
- 14 Jul 1998 No-Development-Reported for Herpes simplex virus infections in Belgium (Unknown route)
- 14 Jul 1998 No-Development-Reported for HIV infections treatment in Belgium (Unknown route)
- 14 Jul 1998 No-Development-Reported for HIV infections treatment in Venezuela (Unknown route)